Events
05.04.2018

Meet us at BIO International Convention 2018 in Boston, MA, USA on 4-7 June, 2018

Cromos™ Pharma will participate in one-on-one meetings at BIO International Convention 2018 in Boston, MA, USA on 4-7 June, 2018. The convention is a major networking and education event the key benefits of which are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 1,500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries.

Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in Central/Eastern Europe, in the post-Soviet bloc, and in the US. The company provides a full spectrum of trial-related services which includes regulatory consulting and compliance, medical writing, enrollment feasibility assessments, monitoring, project management and warehousing/logistics. Cromos Pharma has vast experience across broad therapeutic areas and phases of clinical research. The company’s focus in biologics has been primarily on late phase studies in oncology/hematology, immunology and CNS.

To organize a meeting with us, either email inquiry@cromospharma.com, or use the meeting's networking site.
Other Events:
news

Connect with Cromos Pharma at MAGI's Clinical Research vConference

Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).

17.09.2020
news

Join us at Bio in Philadelphia on June 3-6, 2019

16.05.2019
news

Meet us at Asco Annual Meeting 2019 In Chicago, USA on May 31 – June 4, 2019

13.05.2019
news

Meet us at the 11th Dia China Annual Meeting 2019 in Beijing, China on 20-23 May, 2019

30.04.2019
news

Join Cromos™ Pharma at the 12th European Biosimilars Congress in Berlin, Germany on 15-16 April, 2019

26.03.2019
news

2019 J.P. Morgan 37th Annual Healthcare Conference

10.12.2018